NCT02940548View on ClinicalTrials.gov

Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness

PHASE4TerminatedINTERVENTIONAL

Enrollment

99

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Hypertension

Interventions

DRUG

Nifedipine GITS

Nifedipine GITS 30\~60mg/day for 8 weeks

DRUG

Amlodipine besylate

Amlodipine besylate 5\~10mg/day for 8 weeks

Trial Locations (1)

100044

Peking University People's Hospital, Beijing

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

Jing Liu

OTHER

NCT02940548 - Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness | Biotech Hunter | Biotech Hunter